Oseltamivir Phosphate
Oseltamivir Phosphate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Oseltamivir Phosphate; Generic name: OSELTAMIVIR PHOSPHATE; Manufacturer: Asclemed USA, Inc..
| Brand name | Oseltamivir Phosphate |
|---|---|
| Generic name | OSELTAMIVIR PHOSPHATE |
| Manufacturer | Asclemed USA, Inc. |
| Used for | 1 INDICATIONS & USAGE Oseltamivir phosphate is an influenza neuraminidase inhibitor (NAI) indicated for: • Treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. (1.1) • Prophylaxis of influenza A and B in patients 1 year and older. (1.2) Limitations of Use: • Not a substitute for annual influenza vaccination. (1.3) • Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. (1.3) • Not recommended for patients with end-stage renal disease not undergoing dialysis. (1.3) 1.1 Treatment of Influenza Oseltamivir phosphate capsules are indicated |
| Dosage | 2 DOSAGE & ADMINISTRATION Treatment of influenza ( 2.2) • Adults and adolescents (13 years and older): 75 mg twice daily for 5 days • Pediatric patients 1 to 12 years of age: Based on weight twice daily for 5 days • Pediatric patients 2 weeks to less than 1 year of age: 3 mg/kg twice daily for 5 days • Renally impaired adult patients (creatinine clearance >30 to 60 mL/min): Reduce to 30 mg twice daily for 5 days (2.4) • Renally impaired adult patients (creatinine clearance >10 to 30 mL/min): Red |
| Active ingredient(s) | OSELTAMIVIR PHOSPHATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00be0870-2ebb-46e3-9e98-a8f068ec664a |